BIO-FD&C Co.,Ltd. (KOSDAQ:251120)
South Korea · Delayed Price · Currency is KRW 10,240
+690 (7.23%)
At close: Oct 16, 2026
BIO-FD&C Market Cap
BIO-FD&C has a market cap or net worth of 89.04 billion as of October 16, 2026. It is the 28,702nd most valuable company in the world and the 1,396th biggest in South Korea. Its market cap has decreased by 39.66% in one year.
Market Cap
89.04B
Enterprise Value
33.79B
Revenue
19.53B
Global Rank
Country Rank
#1,396 South Korea
PE Ratio
13.65
ChartMarket Cap Chart
Since February 21, 2022, BIO-FD&C's market cap has decreased from 193.04B to 89.04B, a decrease of -53.87%. That is a compound annual growth rate of -15.32%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2026 | 89.04B | -35.19% |
| Dec 30, 2025 | 137.39B | 14.33% |
| Dec 30, 2024 | 120.17B | -2.12% |
| Dec 28, 2023 | 122.78B | -16.94% |
| Dec 29, 2022 | 147.83B | -23.42% |
| Feb 21, 2022 | 193.04B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Y-Biologics | 102.96B |
| AriBioLab | 102.53B |
| Cell Biotech | 101.77B |
| Prestige Biologics | 100.61B |
| CORESTEMCHEMON | 84.33B |
| Choong Ang Vaccine Laboratory | 82.39B |
| EyeGene | 78.94B |
| CHOOLIP & SCIENCES | 78.74B |